TNX-102 Approval Status
- FDA approved: No
- Brand name: TNX-102
- Generic name: cyclobenzaprine hydrochloride
- Company: Tonix Pharmaceuticals Holding Corp.
- Treatment for: Post Traumatic Stress Disorder
TNX-102 (cyclobenzaprine) is a sublingual formulation of an approved skeletal muscle relaxant in development for the treatment of patients with post-traumatic stress disorder (PTSD).
Development Status and FDA Approval Process for TNX-102
|Jun 10, 2014||Tonix Pharmaceuticals Receives IND Clearance From FDA for TNX-102 in Post-Traumatic Stress Disorder|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.